Hutchmed China-adr (HCM) 13F Positioning & Ownership Changes (Q2 2026)

HCM ranks #5872 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

56 institutions disclose a position in HCM, but none treat it as a major bet — even XY Capital Ltd, its most concentrated holder, allocates just 1.1% of its own portfolio to it.

Vanguard Group has added to its HCM position for two straight quarters, increasing it by $233.3K to reach $458.4K today.

Schroder Investment Management Group has trimmed its HCM position for two straight quarters, cutting it by $14.6M while still holding $15.8M.

HCM is down 1.7% today, but institutions show net buying of $1.5M this quarter — a divergence between today's price move and the underlying institutional flow.

HCM reported a net loss of $106.0M over the trailing twelve months.

• Not yet profitable — net loss of $106.0M over the trailing twelve months
• Revenue declined 4.3% year over year
• Net income declined year over year, from -$74.8M to -$106.0M
• Operating cash flow was negative, using $64.7M in cash
• Current ratio of 4.96x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.41x equity — within a conventional range